# US 2016/0235886 A1 · Wet-pack intraocular lens materials with high refractive index

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2016/0235886 A1
- Document ID: US20160235886A1
- Status: Published application
- Kind: A1
- Application number: 15/006,287
- Filed: 2016-01-26
- Published: 2016-08-18
- Earliest claimed: 2015-02-16
- Assignees: Novartis AG
- Applicants: Novartis AG
- Inventors: Xuwei Jiang; Douglas Schlueter; Walter Laredo
- Web page: https://patentgrep.com/patent/US20160235886A1

## CPC

- C08F 220/302: {and two or more oxygen atoms in the alcohol moiety}
- A61F 2/16: Intraocular lenses
- A61L 27/16: obtained by reactions only involving carbon-to-carbon unsaturated bonds
- A61L 27/18: obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
- A61L 27/26: Mixtures of macromolecular compounds
- A61L 27/50: Materials characterised by their function or physical properties {, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials}
- A61L 2430/16: for reconstruction of eye parts, e.g. intraocular lens, cornea
- C08F 220/305: {and containing a polyether chain in the alcohol moiety}
- C08F: MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- A61F: FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS (dental prosthetics A61C)
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)

## Abstract

Intraocular lens materials are disclosed. They are soft and very deformable and have a high refractive index, and a high glistening resistance in fully hydrated state. They are particularly suitable for making wet-packed intraocular lenses (IOLs) which can be delivered through sub 2.0 mm incisions.

## Claims

### Claim 1

A polymeric intraocular lens material, which is polymerization product of a polymerizable composition comprising
(a) from about 10% to about 30% by weight of a hydrophilic monomer relative to the total amount of all polymerizable components, wherein the hydrophilic monomer is hydroxyethylmethacrylate, hydroxyethylacrylate, N-hydroxyethylmethacrylamide, N-hydroxyethylacrylamide, N,N-dimethylacrylamide, N,N-dimethylmethacrylamide, or a combination thereof,
(b) from about 20% to about 85% by weight of one or more poly(phenyl ether)-containing monomers of formula (I) relative to the total amount of all polymerizable components
wherein:
R1 is H or CH3;
Ra, Rb, Rc, Rd, Re, Rf, Rg, Rh, and Ri independent of one another are H, C1-C12 alkyl, or C1-C12 alkoxy;
Bp is a direct bond, (CH2)m1, or (OCH2CH2)m2, in which m1 is 2-6 and m2 is 1-10;
n1 is an integer from 1 to 9;
n2 is an integer from 0 to 6;
Yp is a direct bond, O, S, OC(═O)NH, NHC(═O)NH, or NR′ in which R′ is H, C1-C10 alkyl, C6H5, or CH2C6H5,
(c) from 0 to about 50% by weight of one or more aryl acrylic monomers of formula (II) relative to the total amount of all polymerizable components
wherein A1 is H or CH3; B1 is (CH2)m1 or [O(CH2)2]Z1 in which m1 is 2-6 and z1 is 1-10;
Y1 is a direct bond, O, S, or NR′ in which R′ is H, CH3, Cn′H2n′+1 in which n′=1-10, iso-OC3H7, C6H5, or CH2C6H5; W1 is 0-6, provided that m1+w1≦8; and D1 is H, Cl, Br, C1-C4 alkyl, C1-C4 alkoxy, C6H5, or CH2C6H5, and
(d) one or more polymerizable crosslinking agents,
wherein the listed components and any additional polymerizable components add up to 100% by weight,
wherein the intraocular lens material in a fully-hydrated state has: a glass transition temperature of less than 22° C., a refractive index of 1.55 or greater measured at 589 nm and at room temperature (23±2° C.), an equilibrium water content of less than 5.0% by weight at a temperature of from 16° C. to 45° C., a Young's modulus of less than 80 MPa, an elongation of at least 100%, a 100% secant modulus of less than 6.0 MPa, and a glistening resistance characterized by having no bright field microvacuoles and about 10 or less microvacuoles per viewing screen.

### Claim 2 (depends on 1)

The intraocular lens material of claim 1, wherein the intraocular lens material in the fully hydrated state is substantially free age-related degradation as measured by low surface light scattering of less than 30 CCT units (computer-compatible-tape units) after 10-years accelerated aging (90° C., 81 days in a Balanced Salt Solution, BSS).

### Claim 3 (depends on 2)

The intraocular lens material according to claim 2, wherein the polymerizable composition comprises from about 15% to about 25% by weight of the hydrophilic monomer.

### Claim 4 (depends on 2)

The intraocular lens material according to claim 2, wherein the polymerizable composition comprises from about 25% to about 75% by weight of said one or more poly(phenyl ether)-containing monomers of formula (I).

### Claim 5 (depends on 2)

The intraocular lens material according to claim 2, wherein the polymerizable composition comprises from about 10% to about 45% by weight of said one or more aryl acrylic monomers of formula (II).

### Claim 6 (depends on 2)

The intraocular lens material of according to claim 2, wherein the polymerizable composition comprises from about 1.0% to about 4.0% by weight of the polymerizable crosslinking agent.

### Claim 7 (depends on 2)

The intraocular lens material according to claim 2, wherein in formula (I), Ra, Rb, Rc, Rd, Re, Rf, Rg, Rh, and Ri independent of one another are H, n1 is an integer from 2 to 6, n2 is an integer from 0 to 4.

### Claim 8 (depends on 2)

The intraocular lens material of claim 2, wherein said one or more poly(phenyl ether)-containing monomers of formula (I) are selected from the group consisting of:

### Claim 9 (depends on 2)

The intraocular lens material of claim 2, wherein said one or more aryl acrylic monomers are: 2-ethylphenoxy acrylate; 2-ethylphenoxy methacrylate; phenyl acrylate; phenyl methacrylate; benzyl acrylate; benzyl methacrylate; 2-phenylethyl acrylate; 2-phenylethyl methacrylate; 3-phenylpropyl acrylate; 3-phenylpropyl methacrylate; 4-phenylbutyl acrylate; 4-phenylbutyl methacrylate; 4-methylphenyl acrylate; 4-methylphenyl methacrylate; 4-methylbenzyl acrylate; 4-methylbenzyl methacrylate; 2-2-methylphenylethyl acrylate; 2,2-methylphenylethyl methacrylate; 2,3-methylphenylethyl acrylate; 2,3-methylphenylethyl methacrylate; 2,4-methylphenylethyl acrylate; 2,4-methylphenylethyl methacrylate; 2-(4-propylphenyl)ethyl acrylate; 2-(4-propylphenyl)ethyl methacrylate; 2-(4-(1-methylethyl)phenyl)ethyl acrylate; 2-(4-(1-methylethyl)phenyl)ethyl methacrylate; 2-(4-methoxyphenyl)ethyl acrylate; 2-(4-methoxyphenyl)ethyl methacrylate; 2-(4-cyclohexylphenyl)ethyl acrylate; 2-(4-cyclohexylphenyl)ethyl methacrylate; 2-(2-chlorophenyl)ethyl acrylate; 2-(2-chlorophenyl)ethyl methacrylate; 2-(3-chlorophenyl)ethyl acrylate; 2-(3-chlorophenyl)ethyl methacrylate; 2-(4-chlorophenyl)ethyl acrylate; 2-(4-chlorophenyl)ethyl methacrylate; 2-(4-bromophenyl)ethyl acrylate; 2-(4-bromophenyl)ethyl methacrylate; 2-(3-phenylphenyl)ethyl acrylate; 2-(3-phenylphenyl)ethyl methacrylate; 2-(4-phenylphenyl)ethyl acrylate; 2-(4-phenylphenyl)ethyl methacrylate; 2-(4-benzylphenyl)ethyl acrylate; 2-(4-benzylphenyl)ethyl methacrylate; 2-(phenylthio)ethyl acrylate; 2-(phenylthio)ethyl methacrylate; 2-benzyloxyethyl acrylate; 3-benzyloxypropyl acrylate; 2-benzyloxyethyl methacrylate; 3-benzyloxypropyl methacrylate; 2-[2-(benzyloxy)ethoxy]ethyl acrylate; 2-[2-(benzyloxy)ethoxy]ethyl methacrylate; or combinations thereof.

### Claim 10 (depends on 2)

The intraocular lens material of claim 2, wherein said one or more aryl acrylic monomers are: 2-phenylethyl acrylate; 3-phenylpropyl acrylate; 4-phenylbutyl acrylate; 5-phenylpentyl acrylate; 2-benzyloxyethyl acrylate; 3-benzyloxypropyl acrylate; 2-[2-(benzyloxy)ethoxy]ethyl acrylate; their corresponding methacrylates, or combinations thereof.

### Claim 11 (depends on 2)

The intraocular lens material of claim 2, wherein the polymerizable crosslinking agents are selected from the group consisting of ethylene glycol dimethacrylate; diethylene glycol dimethacrylate; triethylene glycol dimethacrylate, tetraethylene glycol dimethacrylate, allyl methacrylate; 1,3-propanediol dimethacrylate; 2,3-propanediol dimethacrylate; 1,6-hexanediol dimethacrylate; 1,4-butanediol dimethacrylate; ethylene glycol diacrylate; diethylene glycol diacrylate; triethylene glycol diacrylate, tetraethylene glycol diacrylate, allyl acrylate; 1,3-propanediol diacrylate; 2,3-propanediol diacrylate; 1,6-hexanediol diacrylate; 1,4-butanediol diacrylate; N,N′-hexamethylene bisacrylamide; N,N′-hexamethylene bismethacrylamide; N,N′-dihydroxyethylene bisacrylamide; N,N′-dihydroxyethylene bismethacrylamide; N,N′-methylene bisacrylamide; N,N′-methylene bismethacrylamide; CH2═C(CH3)C(═O)O—(CH2CH2O)p—C(═O)C(═O)C(CH3)═CH2 where p=1-50; CH2═CHC(═O)O—(CH2CH2O)p—C(═O)CH═CH2 where p=1-50; CH2═C(CH3)C(═O)O(CH2)tO—C(═O)C(CH3)═CH2 where t=3-20; CH2═CHC(═O)O(CH2)tO—C(═O)CH═CH2 where t=3-20, and combinations thereof.

### Claim 12 (depends on 11)

The intraocular lens material of claim 11, wherein the polymerizable crosslinking agents are selected from the group consisting of 1,6-hexanediol diacrylate, 1,4-butanediol diacrylate, N,N′-hexamethylene bisacrylamide, and combinations thereof.

### Claim 13 (depends on 2)

The intraocular lens material of claim 2, wherein the polymerizable composition comprises a polymerizable UV-absorbing agent.

### Claim 14 (depends on 13)

The intraocular lens material of claim 13, wherein the polymerizable UV-absorbing agent is 2-(2H-benzo[d][1,2,3]triazol-2-yl)-4-methyl-6-(2-methylallyl)phenol, N-[2-[4-hydroxy-3-[2-(2-methylphenyl)diazenyl]phenyl]ethyl]methacryamide, or a combination thereof.

### Claim 15 (depends on 2)

The intraocular lens material claim 2, wherein the hydrophilic monomer is hydroxyethylmethacrylate, hydroxyethylacrylate, N-hydroxyethylacrylamide, N,N-dimethylacrylamide, or a combination thereof.

### Claim 16 (depends on 2)

The intraocular lens material of claim 2, wherein the hydrophilic monomer is hydroxyethylmethacrylate, hydroxyethylacrylate, or a combination thereof.

### Claim 17 (depends on 2)

The intraocular lens material of claim 2, wherein the hydrophilic monomer is hydroxyethylmethacrylate.

### Claim 18 (depends on 2)

The intraocular lens material of claim 2, wherein the intraocular lens material in the fully-hydrated state has at least one property selected from the group consisting of: a glass transition temperature of less than 17° C.; an equilibrium water content of from about 1% to about 4.5% by weight at a temperature of from 16° C. to 45° C.; a Young's modulus of from about 1 MPa to about 60 MPa; an elongation at break of at least 110%; a 100% secant modulus of about 4.5 MPa or less; and combinations thereof.

### Claim 19 (depends on 2)

The intraocular lens material of claim 2, wherein the intraocular lens material in the fully-hydrated state has a glass transition temperature of less than 12° C.; an equilibrium water content of from about 1.5% to about 4.0% by weight at a temperature of from 16° C. to 45° C.; a Young's modulus of from about 5 MPa to 20 MPa; an elongation at break of from 130% to 300%; a 100% secant modulus of about 3.0 MPa or less; and combinations thereof.

### Claim 20 (depends on 2)

A wet-pack intraocular lens comprising or consisting essentially of an intraocular lens material of claim 2.
